Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis
July 30, 2010
Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis
Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal …
Read more on News-Medical-Net
Related Blogs
- Related Blogs on Aerosol
- First-Place Video Contest Features Dancing Aerosol Can « CSPA Info …
- Pro Tan Competition Color Aerosol Applicator 16-Ounce Bottle …
- Related Blogs on allergic
- What is the best allergy medicine to take if you are allergic to …
- Thrive Nightclub
- Related Blogs on From
- A Farewell to J.D. Salinger from the New York Public Library …
- New Interactive Virtual Timeline from British Library « ResourceShelf
- Pediatrician Rowlett
Comments
Got something to say?



